Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $169
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn maintains an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) and raises the price target from $167 to $169.
July 18, 2024 | 9:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley analyst Terence Flynn maintains an Equal-Weight rating on Johnson & Johnson and raises the price target from $167 to $169.
The raised price target from $167 to $169 by Morgan Stanley indicates a slightly more positive outlook on Johnson & Johnson's stock. This could lead to a modest increase in investor confidence and a potential short-term uptick in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100